financetom
Business
financetom
/
Business
/
Lumen Technologies Partners with Meta to Enhance Network Capacity
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lumen Technologies Partners with Meta to Enhance Network Capacity
Oct 21, 2024 6:49 AM

09:04 AM EDT, 10/21/2024 (MT Newswires) -- Lumen Technologies ( LUMN ) said Monday it has partnered with Meta (META) to boost Meta's network capacity and support the social network company's AI initiatives through the Private Connectivity Fabric initiative.

The company said the partnership will offer Meta secure, on-demand bandwidth, providing the flexibility to meet its computing demands and serve billions of users daily.

Financial terms of the partnership were not disclosed.

LUMN shares were up over 17% while META shares were down 0.1% in recent premarket activity.

Price: 7.90, Change: +1.16, Percent Change: +17.21

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
IES Holdings to Acquire Gulf Island Fabrication
IES Holdings to Acquire Gulf Island Fabrication
Nov 7, 2025
HOUSTON and THE WOODLANDS, Texas, Nov. 07, 2025 (GLOBE NEWSWIRE) -- IES Holdings, Inc. ( IESC ) (“IES”) and Gulf Island Fabrication, Inc. ( GIFI ) (“Gulf Island”) today announced that they have entered into a definitive agreement, providing for the acquisition of Gulf Island, a leading steel fabricator and service provider to the industrial, energy and government sectors, by...
US FDA extends review of Rhythm's drug for brain damage-related obesity
US FDA extends review of Rhythm's drug for brain damage-related obesity
Nov 7, 2025
Nov 7 (Reuters) - Rhythm Pharmaceuticals ( RYTM ) said on Friday the U.S. Food and Drug Administration has extended the review period for expanded approval of its drug to treat a rare form of obesity, caused due to brain damage, by three months. The FDA extended the review of Imcivree from December 20 to March 20, 2026, the company...
Form 8.3
Form 8.3
Nov 7, 2025
LONDON--(BUSINESS WIRE)--   FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of...
Tredegar Q3 net income rises to $7.1 mln, warns of tariff impact
Tredegar Q3 net income rises to $7.1 mln, warns of tariff impact
Nov 7, 2025
Overview * Tredegar ( TG ) Q3 net income from continuing ops rises to $7.1 mln from a loss last year * Company's Q3 sales increase 33% yr/yr due to higher volume and metal cost pass-through * EBITDA from ongoing operations for Aluminum Extrusions rises significantly yr/yr Outlook * Company evaluating cost reduction opportunities to be realized in 2026 *...
Copyright 2023-2026 - www.financetom.com All Rights Reserved